ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 84 filers reported holding ADICET BIO INC in Q3 2023. The put-call ratio across all filers is 7.96 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $62,247 | -24.6% | 45,436 | +33.7% | 0.00% | – |
Q2 2023 | $82,582 | -62.5% | 33,984 | -11.2% | 0.00% | – |
Q1 2023 | $220,331 | -86.3% | 38,252 | -78.8% | 0.00% | – |
Q4 2022 | $1,613,223 | -6.1% | 180,450 | +49.4% | 0.00% | – |
Q3 2022 | $1,718,000 | +420.6% | 120,782 | +433.6% | 0.00% | – |
Q2 2022 | $330,000 | -53.5% | 22,636 | -36.3% | 0.00% | – |
Q1 2022 | $710,000 | -44.6% | 35,538 | -51.5% | 0.00% | – |
Q4 2021 | $1,281,000 | +1193.9% | 73,258 | +477.7% | 0.00% | – |
Q3 2021 | $99,000 | +20.7% | 12,681 | +60.2% | 0.00% | – |
Q2 2021 | $82,000 | -58.2% | 7,914 | -47.3% | 0.00% | – |
Q1 2021 | $196,000 | +3166.7% | 15,005 | +3227.1% | 0.00% | – |
Q4 2020 | $6,000 | -78.6% | 451 | -80.7% | 0.00% | – |
Q3 2020 | $28,000 | – | 2,340 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |